Company: BTBT
Filing Date: 2025-06-25
Form Type: 424B5
Source: 0001213900-25-057815
Chunk: 8

Company: Bit Digital, Inc
Filing Date: 2025-06-25
Form: 424B5
Chunk 8
---
                      ordinary shares from us.                                                                                                                                                                                        |
| Ordinary shares outstanding after this offering |     | ordinary shares (or                      ordinary shares if the underwriters exercise their option to purchase additional shares in full).                                                                                                                                                                                                                                           |
| Use of proceeds                                 |     | We estimate that we will receive net proceeds of approximately $ million from the sale of the ordinary shares offered by us in this offering (or approximately $ million if the underwriters exercise their option to purchase an additional                      ordinary shares in full), after deducting the underwriting discount and estimated offering expenses payable by us. 
 We intend to use the net proceeds from the sale of securities under                                                                                                                                                                                                                                                                                                                  
 this prospectus supplement to purchase Ethereum. See “Use of Proceeds.”                                                                                                                                                                                                                                                                                                              |
| Dividend Policy                                 |     | We have never declared or paid any cash dividends on our ordinary shares. We have no present plan to declare and pay any dividends on our ordinary shares in the near future. We currently intend to retain most, if not all, of our available funds and any future earnings to operate and expand our business. See “Dividend Policy.”                                              |
| Risk factors                                    |     | Investing in our ordinary shares involves a high degree of risk. You should read the section titled “Risk Factors” beginning on page S-4 and the other information included, or incorporated by reference, in this prospectus supplement for a discussion of some of the risks and uncertainties you should carefully consider before deciding to invest in our ordinary shares.     |
| Nasdaq Capital Market symbol                    |     | “BTBT.”                                                                                                                                                                                                                                                                                                                                                                              |

The number of ordinary shares to be outstanding immediately after the closing of this offering is based on 208,530,871 ordinary shares outstanding as of June 23, 2025 and, except as otherwise indicated, all information in this prospectus supplement (a) does not include the number of shares reserved for future exercise or vesting of awards under our equity incentive plans, and 3,808,039, 10,118,046 and 360,000 shares issuable upon exercise of outstanding RSUs, private warrants and options, respectively, and (b) assumes no exercise by the underwriters in this offering of their option to purchase additional ordinary shares.

<div align='center'>S-3

Risk Factors</div>

An investment in our ordinary
shares involves a high degree of risk. You should carefully consider and evaluate all of the information included and incorporated by
reference in this prospectus, including the risk factors below, in